PlainRecalls
FDA Drug Low Class III Terminated

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

Reported: July 8, 2020 Initiated: May 19, 2020 #D-1376-2020

Product Description

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

Reason for Recall

Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

Details

Units Affected
792 kits
Distribution
Nationwide within the United States only lots distributed by Besse Medical are affected.
Location
Burlington, MA

Frequently Asked Questions

What product was recalled?
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01. Recalled by Flexion Therapeutics, Inc.. Units affected: 792 kits.
Why was this product recalled?
Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded
Which agency issued this recall?
This recall was issued by the FDA Drug on July 8, 2020. Severity: Low. Recall number: D-1376-2020.